Investment analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research note issued on Sunday. The brokerage set a “buy” rating on the stock.
Mannatech Trading Up 6.7 %
NASDAQ:MTEX opened at $15.72 on Friday. The company has a current ratio of 1.25, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44. The firm has a fifty day simple moving average of $10.07 and a 200-day simple moving average of $8.33. Mannatech has a 12 month low of $6.75 and a 12 month high of $15.83. The company has a market capitalization of $29.63 million, a P/E ratio of -19.41 and a beta of 1.04.
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. The firm had revenue of $31.73 million for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
See Also
- Five stocks we like better than Mannatech
- How to Plot Fibonacci Price Inflection Levels
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- 3 Small Caps With Big Return Potential
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- How to Use High Beta Stocks to Maximize Your Investing Profits
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
